Distance, insurance and hidden costs hinder clinical trial participation

Connecting patients to appropriate clinical trials remains a complex endeavor, even when a promising match is identified. The process is hampered by a range of practical obstacles that can derail participation before a trial even begins.

Key barriers include geographic incompatibility, as many trials are concentrated in specific research centers far from patients’ homes, and financial constraints, such as travel costs, lost wages, and insurance limitations that can make enrollment unaffordable. Time considerations also play a critical role; the lengthy screening, consent, and scheduling procedures can conflict with patients’ work, caregiving responsibilities, and overall health management, further discouraging participation.

Addressing these challenges requires coordinated efforts from researchers, payers, and patient advocacy groups to streamline enrollment logistics, expand trial sites, and provide comprehensive support services. By reducing geographic, financial, and temporal hurdles, the clinical research community can improve patient access and accelerate the development of new therapies.